BONNIE DZIESINSKI: Open Payments
NPI 1871893594 · MARYVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$915 in 53 payments from 13 companies in 2025. Trend: 2023 $1,662 · 2024 $1,169 · 2025 $915
Food & beverage: $915
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $198 |
| ABBVIE INC. | 13 | $197 |
| Novo Nordisk Inc | 7 | $130 |
| Lilly USA, LLC | 4 | $69 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $66 |
| Xeris Pharmaceuticals, Inc. | 3 | $58 |
| Axsome Therapeutics, Inc. | 3 | $47 |
| Esperion Therapeutics, Inc. | 2 | $36 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $29 |
| Amgen Inc. | 2 | $27 |
Products named: AIRSUPRA, QULIPTA, FARXIGA, Ozempic, MOUNJARO, CAPLYTA, VRAYLAR, GVOKE HYPOPEN.
Industry payments across TN — which companies pay providers there.
